The BCG Vaccine for COVID-19: First Verdict and Future Directions

Despite of the rapid development of the vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it will take several months to have enough doses and the proper infrastructure to vaccinate a good proportion of the world population. In this interim, the accessibility to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez-Perez, Maria, Sanchez-Tarjuelo, Rodrigo, Shor, Boris, Nistal-Villan, Estanislao, Ochando, Jordi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982405/
https://www.ncbi.nlm.nih.gov/pubmed/33763077
http://dx.doi.org/10.3389/fimmu.2021.632478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982405/
https://www.ncbi.nlm.nih.gov/pubmed/33763077
http://dx.doi.org/10.3389/fimmu.2021.632478

Ejemplares similares